Paul Tudor Jones's STIM Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 124,861 shares of Neuronetics, Inc. (STIM) worth $162,319, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Paul Tudor Jones has initiated a new position in STIM, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Neuronetics (STIM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Neuronetics (STIM) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +124,861 | New Buy | 124,861 | $1.30 |
Paul Tudor Jones's Neuronetics Investment FAQs
Paul Tudor Jones first purchased Neuronetics, Inc. (STIM) in Q2 2026, acquiring 124,861 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Neuronetics, Inc. (STIM) for 1 quarters since Q2 2026.
Paul Tudor Jones's largest addition to Neuronetics, Inc. (STIM) was in Q2 2026, adding 124,861 shares worth $162,319.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 124,861 shares of Neuronetics, Inc. (STIM), valued at approximately $162,319.
As of the Q2 2026 filing, Neuronetics, Inc. (STIM) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Neuronetics, Inc. (STIM) was 124,861 shares, as reported at the end of Q2 2026.